David Stark, executive vice president and chief legal officer of financially strapped Teva Pharmaceutical Industries, said he feels like he can breathe easier for the first time in years thanks to a new CEO who is working to bring stability to the company.
Stark has been with Israel-based Teva, the world’s largest generic drug manufacturer, since 2002. “And it’s been a fairly wild ride,” he said in a recent interview with Corporate Counsel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]